Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianfranco Baronzio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
In Vivo (Athens, Greece)|April 17, 2009
Review. Current role and future perspectives of hyperthermia for prostate cancer treatmentGianfranco Baronzio, Alberto Gramaglia, Gianmaria Fiorentini
In Vivo (Athens, Greece)|January 6, 2007
Hyperthermia and immunity. A brief overviewGianfranco Baronzio, Alberto Gramaglia, Gianmaria Fiorentini
Frontiers in Oncology|August 11, 2015
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidGianfranco Baronzio, Gurdev Parmar, Miriam Baronzio
Seminars in Thrombosis and Hemostasis|November 25, 2003
Tumor microenvironment and hemorheological abnormalitiesGianfranco Baronzio, Isabel Freitas, Hau C Kwaan
Cancer Genomics & Proteomics|October 22, 2014
Tumor interstitial fluid: proteomic determination as a possible source of biomarkersGianfranco Baronzio, Gurdev Parmar, Miriam Baronzio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2010
Is it necessary to deplete the lymphokine activated killers' populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killersIrina Olegovna Chikileva, Irina Z Shubina, Gianfranco Baronzio, et al.
ISRN Oncology|November 16, 2011
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate CancersNatalia Yu Anisimova, Andrey V Sosnov, Nadezhda E Ustyuzhanina, et al.
Immunotargets and Therapy|July 30, 2016
Update on the challenges and recent advances in cancer immunotherapyGianfranco Baronzio, Gurdev Parmar, Irina Zh Shubina, et al.
Anticancer Research|January 31, 2012
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesisGianfranco Baronzio, Laurent Schwartz, Mikhail Kiselevsky, et al.
Investigational New Drugs|July 17, 2012
Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicinLaurent Schwartz, Adeline Guais, Maurice Israël, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
In Vivo (Athens, Greece)|April 17, 2009
Review. Current role and future perspectives of hyperthermia for prostate cancer treatmentGianfranco Baronzio, Alberto Gramaglia, Gianmaria Fiorentini
In Vivo (Athens, Greece)|January 6, 2007
Hyperthermia and immunity. A brief overviewGianfranco Baronzio, Alberto Gramaglia, Gianmaria Fiorentini
Frontiers in Oncology|August 11, 2015
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial FluidGianfranco Baronzio, Gurdev Parmar, Miriam Baronzio
Seminars in Thrombosis and Hemostasis|November 25, 2003
Tumor microenvironment and hemorheological abnormalitiesGianfranco Baronzio, Isabel Freitas, Hau C Kwaan
Cancer Genomics & Proteomics|October 22, 2014
Tumor interstitial fluid: proteomic determination as a possible source of biomarkersGianfranco Baronzio, Gurdev Parmar, Miriam Baronzio, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2010
Is it necessary to deplete the lymphokine activated killers' populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killersIrina Olegovna Chikileva, Irina Z Shubina, Gianfranco Baronzio, et al.
ISRN Oncology|November 16, 2011
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate CancersNatalia Yu Anisimova, Andrey V Sosnov, Nadezhda E Ustyuzhanina, et al.
Immunotargets and Therapy|July 30, 2016
Update on the challenges and recent advances in cancer immunotherapyGianfranco Baronzio, Gurdev Parmar, Irina Zh Shubina, et al.
Anticancer Research|January 31, 2012
Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesisGianfranco Baronzio, Laurent Schwartz, Mikhail Kiselevsky, et al.
Investigational New Drugs|July 17, 2012
Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicinLaurent Schwartz, Adeline Guais, Maurice Israël, et al.
Pageof 2